Kb Financial Partners, LLC Adaptive Biotechnologies Corp Transaction History

Kb Financial Partners, LLC

  • $350 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2022
SELL
$10.12 - $28.9 $4,230 - $12,080
-418 Closed
0 $0
Q4 2021

Feb 18, 2022
BUY
$25.17 - $36.85 $10,521 - $15,403
418 New
418 $12,000
Q3 2021

Nov 16, 2021
SELL
$30.02 - $39.87 $12,818 - $17,024
-427 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$32.22 - $44.59 $13,757 - $19,039
427 New
427 $17,000

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.01B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email